| Literature DB >> 28950916 |
Wei-Hung Cheng1,2, Kuo-Yang Huang3, Po-Jung Huang1,4,5, Chi-Ching Lee6, Yuan-Ming Yeh4, Fu-Man Ku2, Rose Lin2, Mei-Ling Cheng5, Cheng-Hsun Chiu7, Petrus Tang8,9,10,11.
Abstract
BACKGROUND: γ-Carboxymuconolactone decarboxylase (CMD) participates in the β-ketoadipate pathway, which catalyzes aromatic compounds to produce acetyl- or succinyl-CoA, in prokaryotes and yeast. Our previous study demonstrated that expression of a CMD homologue that contains two signatures (dualCMD) is negatively regulated by iron in Trichomonas vaginalis. However, we were not able to identify the components of the β-ketoadipate pathway in the parasite's genome. These observations prompted us to investigate the biological functions of this novel CMD homologue in T. vaginalis.Entities:
Keywords: Basal body; Cell cycle; Iron deficiency; Lateral gene transfer; Trichomonas vaginalis; γ-carboxymuconolactone decarboxylase
Mesh:
Substances:
Year: 2017 PMID: 28950916 PMCID: PMC5615479 DOI: 10.1186/s13071-017-2381-4
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Fig. 1Expression of TvCMD1 in different iron availabilities. Protein levels of TvCMD1 under iron-rich (80 μM FAC) and iron-deficient (180 μM DIP) conditions as detected by western blot. GAPDH was used as the loading control. This result indicated a negative iron regulation of TvCMD1 at protein level
Fig. 2TvCMD1 does not participate in β-ketoadipate degradation pathway. a Aromatic compounds induction assay in T. vaginalis. Western blot was used to monitor the expression of TvCMD1 after incubating with protocatechuate (Pca) and benzoate (Ben) for 3 h. GAPDH was used as the loading control. b, c The detection of aromatic compounds in trichomonad cell lysates. The parent and product ions (m/z) ratio was defined according to multiple reaction monitoring (MRM) of each standard. The quantification of aromatic compounds (protocatechuate, benzoate) in iron-rich (middle panel, IR) and iron-deficient (upper panel, ID) cultured T. vaginalis. Percentage (Y-axis) represents the relative concentration of each compound. The lower panels are the standards (std, 1 ppm) Pca and Ben. The protein induction assay and metabolites detection showed that TvCMD1 is unlikely to catalyze aromatic compounds protocatechuate and benzoate
Fig. 3TvCMD1 is associated with the basal body in T. vaginalis. Immunofluorescence analysis shows anterior localized TvCMD1 (green fluorescence) in iron-rich (a) and iron-deficient (b) cultured cells. TvCMD1 co-localized with basal body marker centrin (red fluorescence) in iron-rich (c) and iron-deficient (d) cells. The nucleus was stained with DAPI (blue fluorescence). The result indicated that TvCMD1 (green color) was colocalized with the basal body (red color) in T. vaginalis. Scale-bars: 5 μm
Fig. 4Iron deficiency induces G2/M arrest in T. vaginalis. Cell cycle stage of T. vaginalis cultured under iron-rich (a) and iron-deficient (b) conditions were assessed by flow cytometry. DNA was stained with propidium iodine (PI) and shown in histograms. The G2/M (arrowhead) phase was indicated. This result indicated that iron deficiency induces G2/M arrest in T. vaginalis
Fig. 5Nocodazole induces expression of TvCMD1 in a time-dependent manner. a Western blotting revealed the expression of TvCMD1 after nocodazole (10 μM) treatment for 0, 3 and 6 h. The iron-rich cultured cells were synchronized by cold incubation for 3 h prior to nocodazole addition (cold). GAPDH was used as the loading control. b The quantified result of nocodazole-treated groups based on penal (a). Asterisks represent the significance of 6 h compared to 0 h as determined through P-value (**P < 0.01). The expression of TvCMD1 could be induced by the treatment of nocodazole, the G2/M inhibitor. Abbreviation: IR, iron-rich (negative control)
Fig. 6Transportation of TvCMD1 in dividing cells. Immunofluorescence analysis shows the distribution of TvCMD1 in di-nucleated dividing cells. TvCMD1 is shown in green, basal body in red and the nucleus in blue. The images showed that TvCMD1 was expressed and translocated to/ from the basal body when cells underwent cytokinesis. Scale-bars: 5 μm